Lambros Chrones, MD

Validation of a Mobile Application Version of the Cognition Kit Digit Symbol Substitution Test in Patients With Major Depressive Disorder

Objective: The primary objective of this study was to evaluate the convergent validity of the Cognition Kit Digit Symbol Substitution Test (DSST) mobile app among patients with major depr...

Maggie McCue , MS, RD;

Ben Fehnert , MA;

Orly Lipsitz , BSc;

Mehala Subramaniapillai , BSc(Hons), MSc;

Nelson Rodrigues , MS;

Roger McIntyre , MD, FRCPC;

Lambros Chrones , MD;

James King , MA;

Sharif Uddin , MS;

Kevin Kratiuk , BS;

Joshua Rosenblat , MD, MSc, FRCPC;

Rodrigo Masur , MD, PhD;

10/08/2020

Characterizing Management of Depression in a Primary Care Setting

Introduction: Depression is an important cause of disability in the US and is largely managed by primary care providers (PCPs). Understanding how PCPs manage depression is an important st...

Shruti Vaidya , MS;

Ivelina Popova , BSc;

Anqi Jin , PhD;

Sheetal Patel , MD;

Lambros Chrones , MD;

Alice Pressman , PhD, MS;

Maja Kuharic , PhD;

Maelys Touya , MSc, PharmD;

Debra Lawrence , PhD, MBA, MS;

Kristen Azar , RN, MSN, MPH, FAHA;

10/08/2020

Incremental Burden of Relapse in Patients with Major Depressive Disorder

Objective: Assessment of incremental clinical and economic burdens of relapse in patients with major depressive disorder (MDD).

Anne Kangethe , MPH, PharmD, PhD;

Lambros Chrones , MD;

Themmi Evangelatos , MS, PharmD;

Debra Lawrence , PhD, MBA, MS;

Michael Polson , MS, PharmD;

11/22/2019

Assessment of Adherence and Persistence Among Patients With Major Depressive Disorder Enrolled in the tAccess Patient Support Program

Objective: To assess the impact of tAccess patient support program (PSP) on adherence and persistence among adult patients with major depressive disorder (MDD). tAccess PSP, a free progra...

Maggie McCue , MS, RD;

Janna Manjelievskaia , PhD, MPH;

Lambros Chrones , MD;

Maelys Touya , MSc, PharmD;

Debra Lawrence , PhD, MBA, MS;

11/22/2019

Validation of Goal Attainment Scaling for Depression: Initial Findings From an Open-label Study in Patients Switching to Vortioxetine

Goal attainment scaling (GAS) for evaluating individualized patient treatment goals and progress was adapted for MDD (GAS-D) in an open-label study in patients switching to vortioxetine (...

Maggie McCue , MS, RD;

Lambros Chrones , MD;

Anna Eramo , MD;

Mark Opler , PhD, MPH;

Andrea Norcini Pala , PhD;

Sagar Parikh , MD;

David Hellerstein , MD;

03/01/2019